Is mitoxantrone hydrochloride associated with secondary acute myeloid leukaemia or myelodysplastic syndrome?

Mitoxantrone hydrochloride has been associated with secondary acute myeloid leukaemia or myelodysplastic syndrome when used alone, especially when combined with other antineoplastic agents and/or radiotherapy, so its benefit-to-risk ratio should be assessed before treatment.